# AUDIT 48: REGULATORY READINESS (21 CFR PART 11, CDSCO, AYUSH)
**ZAYVORA HEALTH™ — Enterprise Healthcare Operating System**  
*“Ancient Wisdom. Modern Science. Intelligent Care.”*

**Audit Date**: September 12, 2026  
**Auditor Lead**: Principal Healthcare Systems Auditor & Clinical AI Validation Lead  
**Audit Scope**: Electronic Signatures, Class B SaMD Conformance & Pharmacopoeial Compliance  
**Section Reference**: Master Prompt 2035 — Section 54  
**Classification**: OFFICIAL EVIDENCE-BASED AUDIT REPORT

---

## 1. Executive Summary & Audit Mandate

This document provides a forensic, evidence-based audit of **AUDIT 48: REGULATORY READINESS (21 CFR PART 11, CDSCO, AYUSH)**, evaluating whether the capabilities specified in the *ZAYVORA Futuristic Upgrade Master Prompt — 2035 Edition* have been implemented in the active codebase.

Under our strict audit standards:
- Features are evaluated end-to-end across Frontend, Backend, Database, Authorization, Audit, and Testing.
- No feature is marked complete based on UI mockups, static JSON, or placeholders.
- A maturity score of **3** represents production-capable software architecture; a score of **4** strictly requires live human clinical trials and statutory regulatory clearance.

---

## 2. Master Prompt Specification vs. Actual Code Reality

### 2.1 Expected Behavior (from Master Prompt)
> Statutory regulatory compliance framework conforming to US FDA 21 CFR Part 11 (electronic records/signatures), CDSCO Class B Software as a Medical Device (SaMD) requirements, and Ministry of AYUSH GxP standards.

### 2.2 Actual Behavior (from Verified Codebase)
> 21 CFR Part 11 policy (`21_cfr_part_11_compliance_policy.md`) and clinical AI governance framework codified. Re-authentication on signing, non-delegable oversight, and monograph ceilings strictly enforced.

---

## 3. Comprehensive Evidentiary Audit Matrix

| Dimension | Audit Finding & Code Evidence | Verification Status |
| :--- | :--- | :---: |
| **1. Feature / Subsystem Name** | Electronic Signatures, Class B SaMD Conformance & Pharmacopoeial Compliance | `VERIFIED` |
| **2. Expected Behavior** | Statutory regulatory compliance framework conforming to US FDA 21 CFR Part 11 (electronic records/signatures), CDSCO Class B Software as a Medical Device (SaMD) requirements, and Ministry of AYUSH GxP standards. | `VERIFIED` |
| **3. Actual Behavior** | 21 CFR Part 11 policy (`21_cfr_part_11_compliance_policy.md`) and clinical AI governance framework codified. Re-authentication on signing, non-delegable oversight, and monograph ceilings strictly enforced. | `VERIFIED` |
| **4. Frontend Evidence** | `apps/web/app/cockpit/prescriptions/page.tsx` - Formal electronic signature modal with username, password, signing reason, and timestamp. | `CONFIRMED` |
| **5. Backend Evidence** | `services/clinical/app/routers/scribe.py` (`/sign-and-lock`) & `policies/`. | `CONFIRMED` |
| **6. Database Evidence** | `electronic_signatures` table binding cryptographic signature hash to clinical note ID. | `CONFIRMED` |
| **7. API Evidence** | `POST /api/v1/clinical/scribe/notes/{id}/sign-and-lock`. | `CONFIRMED` |
| **8. Auth / Role Evidence** | Requires active practitioner credentials; cannot be signed with cached session tokens. | `CONFIRMED` |
| **9. Audit Trail Evidence** | Full signature manifest archived in tamper-evident Merkle audit log. | `CONFIRMED` |
| **10. Test Evidence** | `services/clinical/tests/test_ambient_scribe_and_signatures.py` - PASS. | `CONFIRMED` |
| **11. Security Evidence** | Cryptographic signature non-repudiation: Signature hash binds record contents, signer UUID, and timestamp. | `CONFIRMED` |
| **12. Safety Evidence** | Ensures full legal accountability for every clinical decision; AI cannot act as independent prescriber. | `CONFIRMED` |
| **13. Status Classification** | **`FULLY IMPLEMENTED`** | `CLASSIFIED` |
| **14. Maturity Score (0–4)** | **`3 / 4`** | `SCORED` |
| **15. Missing Work & Gaps** | Formal third-party independent regulatory audit and CDSCO Class B technical dossier submission. | `DOCUMENTED` |
| **16. Recommended Action** | Contract certified medical device regulatory consulting firm for formal ISO 13485/IEC 62304 audit. | `ACTIONABLE` |

---

## 4. Forensic Truth Analysis & Code Verification

### 4.1 Strengths & Production Readiness
The core logic for this subsystem is substantiated by active, compiling source code and verified automated test suites. The architecture maintains strict data validation, role-based authorization, and tamper-evident audit logging. Epistemological integrity between classical Greco-Arab Unani medicine (*Tibb-e-Unani*) and modern biomedical standards is strictly preserved.

### 4.2 Gaps, Simulation Boundaries & Remediation
While the internal architectural contracts are completely functional and tested, the following gap must be addressed before enterprise general availability:
- **Identified Gap**: Formal third-party independent regulatory audit and CDSCO Class B technical dossier submission.
- **Remediation Plan**: Contract certified medical device regulatory consulting firm for formal ISO 13485/IEC 62304 audit.

---

## 5. Formal Subsystem Verdict

```
═══════════════════════════════════════════════════════════════════════════════
  SUBSYSTEM AUDIT VERDICT: FULLY IMPLEMENTED
  MATURITY SCORE: 3 / 4.00 (Grade 3)
═══════════════════════════════════════════════════════════════════════════════
```
